The glucose-lowering data from the 2019 meta-analysis [2] remains the strongest clinical evidence for a metabolic effect, and even that showed high heterogeneity across trials
Designed for convenient daily use, these fast-absorbing oral drops support appetite regulation, satiety, and healthy metabolic function without the need for injections.* GLP-1/GIP therapy works by supporting pathways involved in appetite control, digestion, insulin response, and energy balance
These include extended-release formulations, combination therapies, and targeted molecular treatments designed to improve efficacy, minimize side effects, and enhance patient adherence
Rybelsus, the oral form of semaglutide, should be stored at room temperature in a dry place